James Holland (Q139604): Difference between revisions

From geokb
(‎Changed an Item: added knows about claims from OpenAlex topics)
(‎Changed an Item: added knows about claims from OpenAlex topics)
Property / knows about
 
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / rank
Normal rank
 
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier
prevalence: 60
Amount60
Unit1
 
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / reference
 
Property / knows about
 
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / rank
Normal rank
 
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier
prevalence: 59
Amount59
Unit1
 
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / reference
 
Property / knows about
 
Property / knows about: Acute Myeloid Leukemia / rank
Normal rank
 
Property / knows about: Acute Myeloid Leukemia / qualifier
prevalence: 56
Amount56
Unit1
 
Property / knows about: Acute Myeloid Leukemia / reference
 
Property / knows about
 
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / rank
Normal rank
 
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier
prevalence: 34
Amount34
Unit1
 
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / reference
 
Property / knows about
 
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / rank
Normal rank
 
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier
prevalence: 31
Amount31
Unit1
 
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / reference
 
Property / knows about
 
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / rank
Normal rank
 
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier
prevalence: 28
Amount28
Unit1
 
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / reference
 
Property / knows about
 
Property / knows about: Gene Therapy Techniques and Applications / rank
Normal rank
 
Property / knows about: Gene Therapy Techniques and Applications / qualifier
prevalence: 28
Amount28
Unit1
 
Property / knows about: Gene Therapy Techniques and Applications / reference
 
Property / knows about
 
Property / knows about: Pediatric Cancer and Quality of Life / rank
Normal rank
 
Property / knows about: Pediatric Cancer and Quality of Life / qualifier
prevalence: 27
Amount27
Unit1
 
Property / knows about: Pediatric Cancer and Quality of Life / reference
 
Property / knows about
 
Property / knows about: Lymphoid Neoplasms / rank
Normal rank
 
Property / knows about: Lymphoid Neoplasms / qualifier
prevalence: 27
Amount27
Unit1
 
Property / knows about: Lymphoid Neoplasms / reference
 
Property / knows about
 
Property / knows about: Advancements in Lung Cancer Research / rank
Normal rank
 
Property / knows about: Advancements in Lung Cancer Research / qualifier
prevalence: 26
Amount26
Unit1
 
Property / knows about: Advancements in Lung Cancer Research / reference
 
Property / knows about
 
Property / knows about: Molecular Research on Breast Cancer / rank
Normal rank
 
Property / knows about: Molecular Research on Breast Cancer / qualifier
prevalence: 24
Amount24
Unit1
 
Property / knows about: Molecular Research on Breast Cancer / reference
 
Property / knows about
 
Property / knows about: Cardiotoxicity of Cancer Treatments / rank
Normal rank
 
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier
prevalence: 23
Amount23
Unit1
 
Property / knows about: Cardiotoxicity of Cancer Treatments / reference
 
Property / knows about
 
Property / knows about: Efficacy and Resistance in CML Treatment / rank
Normal rank
 
Property / knows about: Efficacy and Resistance in CML Treatment / qualifier
prevalence: 23
Amount23
Unit1
 
Property / knows about: Efficacy and Resistance in CML Treatment / reference
 
Property / knows about
 
Property / knows about: Immunobiology of Dendritic Cells / rank
Normal rank
 
Property / knows about: Immunobiology of Dendritic Cells / qualifier
prevalence: 23
Amount23
Unit1
 
Property / knows about: Immunobiology of Dendritic Cells / reference
 
Property / knows about
 
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / rank
Normal rank
 
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier
prevalence: 22
Amount22
Unit1
 
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / reference
 
Property / knows about
 
Property / knows about: Expanding Access to Radiotherapy Globally / rank
Normal rank
 
Property / knows about: Expanding Access to Radiotherapy Globally / qualifier
prevalence: 19
Amount19
Unit1
 
Property / knows about: Expanding Access to Radiotherapy Globally / reference
 
Property / knows about
 
Property / knows about: Small Cell Lung Cancer / rank
Normal rank
 
Property / knows about: Small Cell Lung Cancer / qualifier
prevalence: 16
Amount16
Unit1
 
Property / knows about: Small Cell Lung Cancer / reference
 
Property / knows about
 
Property / knows about: Globalization of Law and Legal Methodology / rank
Normal rank
 
Property / knows about: Globalization of Law and Legal Methodology / qualifier
prevalence: 15
Amount15
Unit1
 
Property / knows about: Globalization of Law and Legal Methodology / reference
 
Property / knows about
 
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / rank
Normal rank
 
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier
prevalence: 14
Amount14
Unit1
 
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / reference
 
Property / knows about
 
Property / knows about: Natural Killer Cells in Immunity / rank
Normal rank
 
Property / knows about: Natural Killer Cells in Immunity / qualifier
prevalence: 14
Amount14
Unit1
 
Property / knows about: Natural Killer Cells in Immunity / reference
 
Property / knows about
 
Property / knows about: Hematopoietic Stem Cell Biology / rank
Normal rank
 
Property / knows about: Hematopoietic Stem Cell Biology / qualifier
prevalence: 13
Amount13
Unit1
 
Property / knows about: Hematopoietic Stem Cell Biology / reference
 
Property / knows about
 
Property / knows about: The p53 Signaling Network in Cancer Research / rank
Normal rank
 
Property / knows about: The p53 Signaling Network in Cancer Research / qualifier
prevalence: 13
Amount13
Unit1
 
Property / knows about: The p53 Signaling Network in Cancer Research / reference
 
Property / knows about
 
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / rank
Normal rank
 
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier
prevalence: 13
Amount13
Unit1
 
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / reference
 
Property / knows about
 
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / rank
Normal rank
 
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier
prevalence: 12
Amount12
Unit1
 
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / reference
 
Property / knows about
 
Property / knows about: Neuroblastoma Research and Treatment / rank
Normal rank
 
Property / knows about: Neuroblastoma Research and Treatment / qualifier
prevalence: 12
Amount12
Unit1
 
Property / knows about: Neuroblastoma Research and Treatment / reference
 
Property / knows about
 
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / rank
 
Normal rank
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier
 
prevalence: 60
Amount60
Unit1
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / reference
 
Property / knows about
 
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / rank
 
Normal rank
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier
 
prevalence: 59
Amount59
Unit1
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / reference
 
Property / knows about
 
Property / knows about: Acute Myeloid Leukemia / rank
 
Normal rank
Property / knows about: Acute Myeloid Leukemia / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Acute Myeloid Leukemia / qualifier
 
prevalence: 56
Amount56
Unit1
Property / knows about: Acute Myeloid Leukemia / reference
 
Property / knows about
 
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / rank
 
Normal rank
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier
 
prevalence: 34
Amount34
Unit1
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / reference
 
Property / knows about
 
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / rank
 
Normal rank
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier
 
prevalence: 31
Amount31
Unit1
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / reference
 
Property / knows about
 
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / rank
 
Normal rank
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier
 
prevalence: 28
Amount28
Unit1
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / reference
 
Property / knows about
 
Property / knows about: Gene Therapy Techniques and Applications / rank
 
Normal rank
Property / knows about: Gene Therapy Techniques and Applications / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Gene Therapy Techniques and Applications / qualifier
 
prevalence: 28
Amount28
Unit1
Property / knows about: Gene Therapy Techniques and Applications / reference
 
Property / knows about
 
Property / knows about: Pediatric Cancer and Quality of Life / rank
 
Normal rank
Property / knows about: Pediatric Cancer and Quality of Life / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Pediatric Cancer and Quality of Life / qualifier
 
prevalence: 27
Amount27
Unit1
Property / knows about: Pediatric Cancer and Quality of Life / reference
 
Property / knows about
 
Property / knows about: Lymphoid Neoplasms / rank
 
Normal rank
Property / knows about: Lymphoid Neoplasms / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Lymphoid Neoplasms / qualifier
 
prevalence: 27
Amount27
Unit1
Property / knows about: Lymphoid Neoplasms / reference
 
Property / knows about
 
Property / knows about: Advancements in Lung Cancer Research / rank
 
Normal rank
Property / knows about: Advancements in Lung Cancer Research / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Advancements in Lung Cancer Research / qualifier
 
prevalence: 26
Amount26
Unit1
Property / knows about: Advancements in Lung Cancer Research / reference
 
Property / knows about
 
Property / knows about: Molecular Research on Breast Cancer / rank
 
Normal rank
Property / knows about: Molecular Research on Breast Cancer / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Molecular Research on Breast Cancer / qualifier
 
prevalence: 24
Amount24
Unit1
Property / knows about: Molecular Research on Breast Cancer / reference
 
Property / knows about
 
Property / knows about: Cardiotoxicity of Cancer Treatments / rank
 
Normal rank
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier
 
prevalence: 23
Amount23
Unit1
Property / knows about: Cardiotoxicity of Cancer Treatments / reference
 
Property / knows about
 
Property / knows about: Efficacy and Resistance in CML Treatment / rank
 
Normal rank
Property / knows about: Efficacy and Resistance in CML Treatment / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Efficacy and Resistance in CML Treatment / qualifier
 
prevalence: 23
Amount23
Unit1
Property / knows about: Efficacy and Resistance in CML Treatment / reference
 
Property / knows about
 
Property / knows about: Immunobiology of Dendritic Cells / rank
 
Normal rank
Property / knows about: Immunobiology of Dendritic Cells / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Immunobiology of Dendritic Cells / qualifier
 
prevalence: 23
Amount23
Unit1
Property / knows about: Immunobiology of Dendritic Cells / reference
 
Property / knows about
 
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / rank
 
Normal rank
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier
 
prevalence: 22
Amount22
Unit1
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / reference
 
Property / knows about
 
Property / knows about: Expanding Access to Radiotherapy Globally / rank
 
Normal rank
Property / knows about: Expanding Access to Radiotherapy Globally / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Expanding Access to Radiotherapy Globally / qualifier
 
prevalence: 19
Amount19
Unit1
Property / knows about: Expanding Access to Radiotherapy Globally / reference
 
Property / knows about
 
Property / knows about: Small Cell Lung Cancer / rank
 
Normal rank
Property / knows about: Small Cell Lung Cancer / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Small Cell Lung Cancer / qualifier
 
prevalence: 16
Amount16
Unit1
Property / knows about: Small Cell Lung Cancer / reference
 
Property / knows about
 
Property / knows about: Globalization of Law and Legal Methodology / rank
 
Normal rank
Property / knows about: Globalization of Law and Legal Methodology / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Globalization of Law and Legal Methodology / qualifier
 
prevalence: 15
Amount15
Unit1
Property / knows about: Globalization of Law and Legal Methodology / reference
 
Property / knows about
 
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / rank
 
Normal rank
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier
 
prevalence: 14
Amount14
Unit1
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / reference
 
Property / knows about
 
Property / knows about: Natural Killer Cells in Immunity / rank
 
Normal rank
Property / knows about: Natural Killer Cells in Immunity / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Natural Killer Cells in Immunity / qualifier
 
prevalence: 14
Amount14
Unit1
Property / knows about: Natural Killer Cells in Immunity / reference
 
Property / knows about
 
Property / knows about: Hematopoietic Stem Cell Biology / rank
 
Normal rank
Property / knows about: Hematopoietic Stem Cell Biology / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Hematopoietic Stem Cell Biology / qualifier
 
prevalence: 13
Amount13
Unit1
Property / knows about: Hematopoietic Stem Cell Biology / reference
 
Property / knows about
 
Property / knows about: The p53 Signaling Network in Cancer Research / rank
 
Normal rank
Property / knows about: The p53 Signaling Network in Cancer Research / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: The p53 Signaling Network in Cancer Research / qualifier
 
prevalence: 13
Amount13
Unit1
Property / knows about: The p53 Signaling Network in Cancer Research / reference
 
Property / knows about
 
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / rank
 
Normal rank
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier
 
prevalence: 13
Amount13
Unit1
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / reference
 
Property / knows about
 
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / rank
 
Normal rank
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier
 
prevalence: 12
Amount12
Unit1
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / reference
 
Property / knows about
 
Property / knows about: Neuroblastoma Research and Treatment / rank
 
Normal rank
Property / knows about: Neuroblastoma Research and Treatment / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / knows about: Neuroblastoma Research and Treatment / qualifier
 
prevalence: 12
Amount12
Unit1
Property / knows about: Neuroblastoma Research and Treatment / reference
 
Property / OpenAlex ID
 
Property / OpenAlex ID: A5072965952 / rank
 
Normal rank
Property / OpenAlex ID: A5072965952 / qualifier
 
last update: 22 August 2024
Timestamp+2024-08-22T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / OpenAlex ID: A5072965952 / qualifier
 
retrieved: 29 August 2024
Timestamp+2024-08-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 23:34, 29 August 2024

a record for a person added from ORCID based on a contributor to a USGS publication
Language Label Description Also known as
English
James Holland
a record for a person added from ORCID based on a contributor to a USGS publication

    Statements

    22 August 2024
    29 August 2024
    0 references